Some trials show that BMP-7 could be used in the therapy of kidney diseases as recombinant BMP-7 infusions used in the pre-clinical phase decreased fibrosis and inflammation occurring in obstructive uropathy [104] or slowed GFR decline in mice with lupus nephropathy [105]. The gene discussed is BMP7; the disease is kidney disorder.